Relative mRNA expression levels for caspase-2L in neurological disease.

Abstract

Caspase-2L Cp-values (A), RPL13 Cp-values (B), and relative caspase-2L mRNA expression levels (C) do not differ in MCI and AD samples compared to controls. Caspase-2L Cp-values (D), RPL13 Cp-values (E), and relative caspase-2L mRNA expression levels (F) do not differ in LBD compared to non-demented PD controls. Caspase-2L Cp-values (G), RPL13 Cp-values (H), and relative caspase-2L mRNA expression levels (I) do not differ in HD compared to controls.</p